ABSTRACT Introduction: Hepatitis C virus (HCV) represents a major health concern, as
nearly 3 million people become newly infected by this pathogen annually. The majority of …

New all‐oral direct‐acting antivirals (DAA) have changed the hepatitis C virus (HCV)
treatment landscape. Given that dermatologists frequently encounter HCV‐infected patients …

DEAR EDITOR, Sporadic porphyria cutanea tarda (PCT) is strongly associated with hepatitis
C virus (HCV) infection in our population. 1–4 Therapeutic options for PCT include …

In 1964, the first human oncovirus, Epstein–Barr virus, was identified in Burkitt lymphoma
cells. Since then, 6 other human oncoviruses have been identified: human papillomavirus …

Abstract Background and Aims Chronic hepatitis C [CHC] is a risk factor for porphyria
cutanea tarda [PCT]. To assess whether ledipasvir/sofosbuvir is effective for treating both …

Porphyria cutanea tarda (PCT) arises from a deficiency of uroporphyrinogen decarboxylase
(UROD) in the liver. Several exogenous risk factors are associated with the acquired form of …

Porphyrias are disorders caused by defects in the biosynthetic pathway of heme. Their
manifestations can be divided into three distinct syndromes, each attributable to the …

Objectives Porphyria cutanea tarda (PCT) is common and usually associated with HCV
chronic infection and HFE polymorphisms. Since DAA IFN-free regimens availability, SVR …

Ultrasonography in a 60-year-old man with chronic hepatitis C (CHC) demonstrated multiple
hyperechoic nodules. Radiological investigations did not reveal any signs of malignancy …

Porphyria cutanea tarda (PCT) is the most common porphyria and has gained more
importance as the prevalence of hepatitis C viral infection rose. There are 2 categories of …